Home » Reports » Stock Report » Market Risers: Blue Star Capital PLC, Fox Marble Holdings PLC, Goldplat plc, ImmuPharma PLC
Blue Star Capital plc

Market Risers: Blue Star Capital PLC, Fox Marble Holdings PLC, Goldplat plc, ImmuPharma PLC

The share price for Blue Star Capital PLC found using EPIC: LON:BLU has stepped up 12.94% or 0.01 points throughout the session so far. Market buyers have stayed positive while the stock has been in play. Range high for the period has seen 0.1 and hitting a low of 0.09. Volume total for shares traded at this point reached 13,008,385 whilst the average number of shares exchanged is 6,598,357. A 52 week high for the stock is 0.23 equating to 0.14 points in difference on the previous days close and a 52 week low being 0.08 a difference of some 0.01 points. Blue Star Capital PLC now has a 20 SMA at 0.11 and the 50 day simple moving average now of 0.13. This puts the market capitalisation now at £2.15m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Blue Star Capital PLC being recorded at Monday, August 5, 2019 at 10:05:46 AM GMT with the stock price trading at 0.1 GBX.

Shares of Fox Marble Holdings PLC with ticker code: LON:FOX has stepped up 3.67% or 0.22 points during today’s session so far. Buyers are a positive bunch during this period. The high for the period has reached 6.35 dropping as low as 6.35. The number of shares traded by this point in time totalled 37,874 with the average number of shares traded daily being 141,920. The 52 week high for the shares is 9.49 equating to 3.36 points in difference on the previous days close and a 52 week low being 4.55 which is a variance of 1.58 points. Fox Marble Holdings PLC has a 20 SMA of 5.91 and a 50 day moving average at 6.67. The current market cap is £14.68m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Fox Marble Holdings PLC being recorded at Monday, August 5, 2019 at 10:42:13 AM GMT with the stock price trading at 6.35 GBX.

The trading price for Goldplat plc ticker code: LON:GDP has risen 7.24% or 0.21 points throughout the session so far. Buyers have remained optimistic throughout the session. The period high has peaked at 3.11 dipping to 2.96. Volume total for shares traded at this point reached 559,518 while the average shares exchanged is 268,287. A 52 week high for the stock is 5.75 amounting to 2.85 points different to the previous business close and a 52 week low sitting at 2.08 a difference of some 0.82 points. Goldplat plc now has a 20 SMA of 2.95 and now the 50 day moving average now at 2.68. The current market capitalisation is £5.21m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Goldplat plc being recorded at Monday, August 5, 2019 at 11:52:41 AM GMT with the stock price trading at 3.11 GBX.

Shares of ImmuPharma PLC ticker lookup code: LON:IMM has moved up 4.26% or 0.4 points during today’s session so far. Investors have stayed positive during this period. The high for the period has peaked at 9.8 and a low of 9.43. Volume total for shares traded during this period was 127,755 whilst the average number of shares exchanged is 669,738. The stock 52 week high is 22.9 which comes in at 13.5 points different to the previous business close and a 52 week low sitting at 8.5 making a difference of 0.9 points. ImmuPharma PLC has a 20 SMA of 9.97 and also a 50 day moving average now at 12.05. The market cap now stands at £16.40m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for ImmuPharma PLC being recorded at Monday, August 5, 2019 at 11:03:20 AM GMT with the stock price trading at 9.8 GBX.

Follow this article (for updates)
X

Follow this article (for updates)

E-mail : *
* Your personal data will be used to support your experience throughout this website and for other purposes described in our Privacy Policy. I hereby agree and consent to the privacy policy.